Enzymatic Debridement Agents for Wounds

Overview

Debridement agents are enzymes, hypertonic saline or other topical formulations that provide selective or non-selective removal of necrotic tissue or debris from a wound. These agents must be covered with a primary dressing.

Features

Debridement agents feature the following general performance properties and attributes:
• Removes necrotic tissue, allowing wound healing to progress
• Some specifically target necrotic tissue to avoid harming fragile new tissue

Indications

Debridement agents are indicated for debridement of necrotic tissue and liquefaction of slough in acute and chronic lesions, such as pressure ulcers, diabetic ulcers, burns, post-operative wounds, trauma wounds, and infected wounds.

Contraindications

Debridement agents are generally contraindicated for use on patients with a known sensitivity to any of the components of the agent.

Warnings

Always read the package insert and use according to manufacturer’s recommendations.

Reimbursement Information

Debridement agents may be part of a procedure billed using a CPT code.

Disclaimer: Information regarding coding, coverage and payment is provide as a service to users. Every effort has been made to ensure the accuracy of the information. However, Kestrel Health Information, Inc. and its subsidiaries do not represent, guarantee or warranty that the coding, coverage and payment information is error-free or that payment will be received. Users should always verify coverage policy, medical necessity requirements and coding instructions, and should review bulletins issued by the specific payer.

Debridement Agents

Overview

Features

Indications

Contraindications

Warnings

Reimbursement Information

On-Demand Webinars

Products

Digital Edition

Content

Guides

Resources

User Center